KING & SPALDING LLP

Lobbying for KANEKA PHARMA AMERICA, LLC · Distributor of life science systems

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · $30,000.00 income · posted Oct 19, 2025

Bills named in this filing 1

Lobbying activity 1

Medicare/Medicaid

Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.